ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.

November 16, 2007

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Nutrition RFP Canceled, Job Added To Existing Contract

April 4, 1975

Thompson Tours Brown’s Brain Science Center.

March 16, 2001

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985